Tissue Repair (TRP) Stock Price, News & Analysis

Company Overview

Tissue Repair Ltd, a clinical stage biopharmaceutical company, developing advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures, as well as other products for veterinary, new bandage, scaffold products, and other therapeutic indications. The company was incorporated in 2012 and is headquartered in Sydney, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$17.23 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Utilities
• Current Symbol: ASX:TRP
• CIK: N/A
• Web: www.tcenergy.com
• Phone: 14039202000
• Fax: N/A
• Employees: 7,480
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$4.14 million
• Net Margins: -231.07%
• Pretax Margin: N/A
• Return on Equity: -21.88%
• Return on Assets: -14.60%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 14.50
• Quick Ratio: 46.23

Sales & Book Value

• Annual Sales: A$1.79 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.30 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 60,460,000
• Free Float: N/A
• Market Cap: A$17.23 million
• Optionable: Not Optionable
• Beta: 0.37